In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

FiscalNote Holdings Inc (NOTE) stock saw a decline, ending the day at $1.33 which represents a decrease of $-0.04 or -2.92% from the prior close of $1.37. The stock opened at $1.45 and touched a low ...

Frontline plc (NYSE:FRO) is a company engaged in seaborne transportation of crude oil and refined products. The company owns ...

Fintel reports that on January 7, 2025, BTIG initiated coverage of Hims & Hers Health (NYSE:HIMS) with a Buy recommendation.

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...

BTIG analyst Thomas Shrader lowered the firm’s price target on Denali Therapeutics (DNLI) to $32 from $35 and keeps a Buy rating on the shares after the company announced topline data from the Phase 2 ...

BTIG Research currently has $40.00 price target on the stock. Several other equities research analysts have also issued reports on ONIT. Keefe, Bruyette & Woods increased their […] ...

BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, ...

BTIG Research’s target price indicates a potential upside of 4.07% from the company’s current price. A number of other brokerages also recently issued reports on REG.

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...